Tuberculosis (TB) is one of the world’s top infectious killers of women. In 2011, half a million women died from TB, including 200,000 HIV-positive women (people with HIV have a higher risk of dying from TB). Encouraging data in the WHO Global Tuberculosis Report 2012 shows that scaling up collaborative TB/HIV activities to improve prevention, treatment and care services help saved an estimated 1.3 million lives (between 2005 and 2011). Last year, 69% of TB patients were tested for HIV in the African Region (up from just 3% in 2004). Expanding access to antiretroviral therapy will have a significant impact on reducing deaths among HIV-positive TB patients in addition to reducing the risk of active TB developing among people who are HIV positive.